Brigatinib versus Crizotinib in ALK Inhibitor-Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial
Journal
Journal of Thoracic Oncology
Journal Volume
16
Journal Issue
12
Pages
2091-2108
Date Issued
2021
Author(s)
Camidge D.R.
Kim H.R.
Ahn M.-J.
Han J.-Y.
Hochmair M.J.
Lee K.H.
Delmonte A.
Garcia Campelo M.R.
Kim D.-W.
Griesinger F.
Felip E.
Califano R.
Spira A.I.
Gettinger S.N.
Tiseo M.
Lin H.M.
Liu Y.
Vranceanu F.
Niu H.
Zhang P.
Popat S.
SDGs
Publisher
Elsevier Inc.
Type
journal article